calcimedica inc glp-1 receptor agonists weight management diabetes treatments GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review calcimedica inc glp-1 receptor agonists
Description
However, several important considerations emerge when combining these interventions
doi: 10.1111/dom.12082

[DOI] [PMC free article] [PubMed] [Google Scholar] 700.Barrera J.G., Jones K.R., Herman J.P., D'Alessio D.A., Woods S.C., Seeley R.J

Expert Opin Pharmacother (2013) 14:228196
